Quidel Quidel Q2 Revenues Dip 12 Percent; Misses on Revenues and EPS Estimates Quidel CEO Douglas Bryant said the firm's base business grew 24 percent year over year, excluding COVID and influenza products. Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business The firms have agreed to transition the business to Beckman, with Quidel receiving annual payments until 2029. OraSure Stock Ticks Up on Rumor of Declined Quidel Acquisition Offer The firm's stock price rose as much as nearly 12 percent on Monday following a report saying that it had rejected a takeover bid from Quidel. Quidel Nabs CE Mark for Savanna Analyzer, Respiratory Panel The new instrument can analyze up to 12 pathogens from a single sample, while the respiratory panel detects influenza A and B, RSV, and COVID-19. Quidel Recalls Lyra SARS-CoV-2 Test Due to Potential False Negative Results The assay is being recalled due to a significant risk of false negative results for patients with relatively high amounts of SARS‐CoV‐2 virus. Jun 1, 2021 GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April Apr 23, 2021 Quidel Preliminary Q1 Revenues Double But Fall Far Short of Expectations Mar 10, 2021 Quidel Guides for Revenues Below Street Estimate, Citing Softening SARS-CoV-2 Test Demand Mar 2, 2021 Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent Feb 19, 2021 Quidel Reports Delay in OTC COVID-19 Antigen Test Claims, Pours Cold Water on M&A Rumors Premium Feb 18, 2021 Quidel Q4 Revenues Increase Sharply on COVID-19 Sales, Beat EPS Estimates Feb 1, 2021 Fulgent Genetics Soars in January as GenomeWeb Index Begins 2021 up 10 Percent Jan 13, 2021 At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market Jan 7, 2021 Quidel Preliminary Q4 Revenues Up Fivefold Dec 23, 2020 Quidel Gets EUA for Rapid, Extraction-Free COVID-19 MDx on Solana System Dec 1, 2020 Veracyte, Twist Bioscience Lead November GenomeWeb Index on Strong Earnings Growth Oct 30, 2020 Quidel Expects SARS-CoV-2 Testing Demand to Continue 'Through 2022, and Beyond' Premium Oct 29, 2020 Quidel Q3 Revenues More Than Triple, Beat Analyst Expectations Oct 1, 2020 Quidel Releases Preliminary Q3 Results, Partners with Biodesix for Big Ten Surveillance Sep 18, 2020 People in the News: New Appointments at Quidel, NeoGenomics, Veracyte, More Sep 8, 2020 As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza Premium Sep 1, 2020 Meridian Bioscience Leads Decliners in August as GenomeWeb Index Falls 4 Percent Aug 27, 2020 As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit Aug 4, 2020 GenomeWeb Index Up 13 Percent in July as Investors Cheer COVID Dx Development Jul 31, 2020 Facing 'Unfathomable' Demand, Quidel Ramps Up SARS-CoV-2 Test Production Premium Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.